Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

Bibliographic Details
Main Authors: Kyoung-Ho Pyo, S. M. Mazidur Rahman, Diana Boraschi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1121120/full
_version_ 1797956391167590400
author Kyoung-Ho Pyo
Kyoung-Ho Pyo
S. M. Mazidur Rahman
Diana Boraschi
Diana Boraschi
Diana Boraschi
Diana Boraschi
author_facet Kyoung-Ho Pyo
Kyoung-Ho Pyo
S. M. Mazidur Rahman
Diana Boraschi
Diana Boraschi
Diana Boraschi
Diana Boraschi
author_sort Kyoung-Ho Pyo
collection DOAJ
first_indexed 2024-04-10T23:48:16Z
format Article
id doaj.art-965714a814fa478fb11c6e11961b4f36
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T23:48:16Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-965714a814fa478fb11c6e11961b4f362023-01-10T21:47:21ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011210.3389/fonc.2022.11211201121120Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease controlKyoung-Ho Pyo0Kyoung-Ho Pyo1S. M. Mazidur Rahman2Diana Boraschi3Diana Boraschi4Diana Boraschi5Diana Boraschi6Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South KoreaYonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, South KoreaInternational Centre for Diarrhoeal Disease Research (iccdr,b), Dhaka, BangladeshShenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, ChinaInstitute of Biochemistry and Cell Biology, National Research Council (CNR), Napoli, ItalyStazione Zoologica Anton Dohrn (SZN), Napoli, ItalyChina-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2022.1121120/fullAXLsmall molecule inhibitorsantibodiestumor therapytherapy of infections
spellingShingle Kyoung-Ho Pyo
Kyoung-Ho Pyo
S. M. Mazidur Rahman
Diana Boraschi
Diana Boraschi
Diana Boraschi
Diana Boraschi
Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
Frontiers in Oncology
AXL
small molecule inhibitors
antibodies
tumor therapy
therapy of infections
title Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
title_full Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
title_fullStr Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
title_full_unstemmed Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
title_short Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
title_sort editorial development of small molecule inhibitors and antibodies targeting axl for tumor therapy and infectious disease control
topic AXL
small molecule inhibitors
antibodies
tumor therapy
therapy of infections
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1121120/full
work_keys_str_mv AT kyounghopyo editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT kyounghopyo editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT smmazidurrahman editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT dianaboraschi editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT dianaboraschi editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT dianaboraschi editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol
AT dianaboraschi editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol